Guardant Health, Inc. (BMV:GH)

SpringWorks Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	522.81	525.54	1,134	141.65	492.2	832.98
Short-Term Investments	-	314.44	35.1	869.58	440.55	961.9
Cash & Short-Term Investments	522.81	839.98	1,169	1,011	932.75	1,795
Cash Growth	-46.99%	-28.12%	15.57%	8.41%	-48.03%	243.32%
Receivables	130.25	110.25	88.78	97.26	97.65	53.3
Inventory	84.06	71.08	61.95	51.6	30.67	22.72
Prepaid Expenses	39.98	33.8	27.74	31.51	53.05	17.47
Total Current Assets	883.43	1,055	1,347	1,192	1,114	1,888
Property, Plant & Equipment	295.91	279.08	302.71	341.92	313.9	100.13
Long-Term Investments	16.1	16.1	106.6	43.3	737.43	246.6
Goodwill	3.29	3.29	3.29	3.29	3.29	3.29
Other Intangible Assets	5.86	6.76	8.98	11.73	14.21	16.16
Other Long-Term Assets	127.4	125.27	17.73	18.15	21.54	17.25
Total Assets	1,332	1,486	1,786	1,610	2,204	2,272
Accounts Payable	44.8	38.55	51.74	68.91	38.52	7.34
Accrued Expenses	113	83.22	72.74	55.79	42.5	38.5
Current Portion of Leases	26.28	29.21	27.95	21.88	12.86	6.63
Current Income Taxes Payable	-	-	-	-	-	4.63
Current Unearned Revenue	54.36	35.47	17.97	17.4	11.33	8.55
Other Current Liabilities	-	39.13	35.53	29.24	89.49	1.16
Total Current Liabilities	238.43	225.58	205.92	193.22	194.69	66.81
Long-Term Debt	1,116	1,143	1,140	1,137	1,135	806.29
Long-Term Leases	192.35	164.29	185.85	210.02	226.05	41.57
Long-Term Unearned Revenue	60.7	41.6	22.9	3.8	-	-
Other Long-Term Liabilities	30.47	51.23	73.11	5.38	3.93	1.52
Total Liabilities	1,637	1,625	1,628	1,550	1,559	916.19
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	2,517	2,444	2,304	1,742	1,658	1,902
Retained Earnings	-2,773	-2,578	-2,142	-1,662	-1,008	-606.59
Comprehensive Income & Other	-3.72	-5.2	-3.68	-19.52	-4.76	2.7
Total Common Equity	-305.48	-139.65	158.68	60.18	645.01	1,298
Minority Interest	-	-	-	-	-	57.1
Shareholders' Equity	-305.48	-139.65	158.68	60.18	645.01	1,356
Total Liabilities & Equity	1,332	1,486	1,786	1,610	2,204	2,272
Total Debt	1,334	1,336	1,354	1,369	1,374	854.49
Net Cash (Debt)	-811.35	-496.07	-185.13	-358.05	257.05	1,187
Net Cash Growth	-	-	-	-	-78.34%	58.02%
Net Cash Per Share	-6.56	-4.04	-1.65	-3.50	2.54	12.17
Filing Date Shares Outstanding	124.71	123.42	121.71	102.66	101.87	100.43
Total Common Shares Outstanding	124.48	123.99	121.63	102.62	101.77	100.21
Working Capital	645	829.53	1,141	998.37	919.44	1,822
Book Value Per Share	-2.45	-1.13	1.30	0.59	6.34	12.96
Tangible Book Value	-314.63	-149.7	146.42	45.16	627.51	1,279
Tangible Book Value Per Share	-2.53	-1.21	1.20	0.44	6.17	12.76
Machinery	183.62	168.94	160.53	133.88	83.39	54.12
Construction In Progress	20.87	28.14	7.51	20.6	55.87	7.83
Leasehold Improvements	104.9	103.57	102.3	99.78	38.7	34.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.